NCT04689516View on ClinicalTrials.gov

Thoracic Fluid Content During Hypervolemic Hemodilution

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

January 2, 2022

Conditions
Pulmonary Edema
Interventions
DEVICE

Thoracic fluid content estimation

The patient will be monitored for thoracic fluid content and LUS score. The infusion will stop if TFC reaches 40 k ohm-1 or after completion of the infused volume. LUS evaluation will be done before the start and after the end of the infusion.

Trial Locations (1)

12511

Cairo University hospitals, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04689516 - Thoracic Fluid Content During Hypervolemic Hemodilution | Biotech Hunter | Biotech Hunter